RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

Gfp:

It's good to hear from you, glad to see that you are still around.

The new management has achieved two essential goals:
1) Cleaned up the fiscal debris from the near-bankruptcy
2) Re-established the IP relationship with U. Illinois

The two questions I have at the moment (you raise some interesting points about the breadth of the UI cannabinoid patent) are:

1) Are they planning to wait out the Phase II now ongoing before doing anything else with the cannabinoid angle? If so--they've got a year or so before that trial is projected to be completed.

2) What is their agenda for the Ampakine compounds still in their control? (the use patents are gone, but they are ancient anyways)

The answers to those questions will determine what their need for additional capital nearterm is...


NeuroPerspective